Biogen Idec and Google X will use sensors and software to collect and analyze data from MS patients. The goals is to understand environmental and biological factors that contribute to the disease’s progression, and why it progresses differently in every patient. Andrew Conrad, head of Life Sciences at Google X, believes that this will lead to earlier interventions and better outcomes.
Sensors, software to understand MS progression
by
Tags: